Hepatitis B virus blood screening: Impact of nucleic amplification technology testing implementation on identifying hepatitis B surface antigen non-reactive window period and chronic infections

Vox Sanguinis

Volumn 96, Issue 4, 2009, Pages 292-297

  Iudicone, P ^a,b   Miceli, M ^b   Palange, M ^b   Agresti, A ^b   Gallo, A ^b   Isacchi, G ^c,d   Girolami, E ^c   Pierelli, L ^b   Mannella, E ^b  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b Laboratory of Serology and Viral Molecular Biology   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Blood donors; Blood safety; HBV infection; NAT screening; Transfusion therapy

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD EXAMINATION; BLOOD TRANSFUSION; CHRONIC HEPATITIS; DNA SCREENING; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; ITALY; MALE; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SCREENING; SEROLOGY; VIRUS LOAD; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; DNA, VIRAL; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 65649096890     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01171.x     Document Type: Article

References (22)

1. Mele A, Tosti ME, Spada E : Epidemiology of acute viral hepatitis: twenty years of surveillance through SEIEVA in Italy and a review of the literature. Rapporti ISTISAN 2006; 06/12
2. Zanetti AR, Tanzi E, Romanò L, Grappasonni I : Vaccination against hepatitis B: the Italian strategy. Vaccine 1993 11 : 521 524 (Pubitemid 23130856)
3. Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Balocchini E, Spada E : Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 2008 46 : 868 875
4. Weber B : Genetic variability of the S gene of Hepatitis B virus: clinical and diagnostic impact. J Clin Virol 2005 32 : 102 112 (Pubitemid 40093960)
5. Bartholomeusz A, Locarnini S : Hepatitis B virus mutation associated with antiviral therapy. J Med Virol 2006 78 : 52 55 (Pubitemid 43993466)
6. Echevarria JM, Avellon A : Hepatitis B virus genetic diversity. J Med Virol 2006 78 : 36 42 (Pubitemid 43993463)
7. Gunther S : Genetic variation in HBV infection: genotype and mutants. J Clin Virol 2006 36 : 3 11 (Pubitemid 44026521)
8. Hollinger FB : Hepatitis B virus infection and transfusion medicine: science and occult. Transfusion 2008 48 : 1001 1026
9. Comanor L, Holland P : Hepatitis B virus blood screening: unfinished agendas. Vox Sang 2007 92 : 278 290
10. Kuhns MC, Busch M : New strategies for blood donor screening for hepatitis B virus. Mol Diag Ther 2006 10 : 77 91
11. Yugi H, Mizui M, Tanaka J, Yoshizawa H : Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience. J Clin Virol 2006 36 : 56 64 (Pubitemid 44016158)
12. Zanetti AR, Romanò L, Zappa A, Velati C : Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. J Clin Virol 2006 36 : 51 55 (Pubitemid 44016157)
13. Allain JP : Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004 86 : 83 91 (Pubitemid 38436885)
14. Vitale F, Tramuto F, Orlando A, Vizzini G, Meli V, Cerame G, Mazzuzzo W, Verdone R, Palazzo U, Villafrate MR, Tagger A, Romano N : Can the serological status of 'anti-HBc alone' be considered a sentinel marker for detection of 'occult' HBV infection? J Med Virol 2008 80 : 577 582
15. Raimondo G, Pollicino T, Cacciola I, Squadrito G : Occult hepatitis B virus infection. J Hepatol 2007 46 : 160 170
16. Allain JP : Epidemiology of Hepatitis B virus and genotype. J Clin Virol 2006 36 : 12 17 (Pubitemid 44016152)
17. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K : Hepatitis B NAT virus-positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Vox Sang 2005 88 : 223 230
18. Satake M, Taira RM, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K : Infectivity of blood components with low hepatitis B virus DNA levels identified in a look back program. Transfusion 2007 47 : 1197 1205 (Pubitemid 46934327)
19. Gerlich WH, Wagner FF, Chudy M, Harritshoj LH, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schuttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E : HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol 2007 79 : S32 S36 (Pubitemid 47479872)
20. Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S : Sensitivity of Hepatitis B virus DNA transcription - mediated amplification testing in hepatitis B surface antigen-positive blood donation. Transfusion 2006 46 : 2047 2052
21. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP : Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBC: implication for future HBV screening policy. Transfusion 2004 44 : 1332 1339 (Pubitemid 39129246)
22. Allain JP, Sarkodie F, Candotti D, Oparem-Sem O : Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Transfusion 2005 45 : 1039 1040 (Pubitemid 40798799)